Benzinga | Aug 13, 2020 06:05AM EDT

PDS Biotechnology Q2 EPS $(0.19) Beats $(0.23) Estimate

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.23) by 17.39 percent. This is a 74.67 percent increase over losses of $(0.75) per share from the same period last year.